Skip to main content

Advertisement

Log in

Towards site-specific nanoparticles for drug delivery application: preparation, characterization and release performance

  • Original Paper
  • Published:
Chemical Papers Aims and scope Submit manuscript

Abstract

Due to the uncontrollable drug release, traditional chemotherapies could cause great side-effects and are detrimental to normal tissue or organs. Therefore, to avoid those side-effects, drug delivery system (DDS) which is capable of releasing drug molecules at target area with controllable rate according to the development of the disease or to certain functions of the organism/biological rhythm, has attracted especially focus in recent years. In this research, we devoted our efforts in constructing a core–shell nanocomposite to meet the above requirements. The superparamagnetic Fe3O4 nanoparticles were chosen as the core to introduce the magnetic guiding as well as site-specific properties in this novel drug carrier. The core was further encapsulated by silica-based molecular sieve MCM-41 (briefly denoted as MS in this research), which was consisted by immense highly ordered hexagonal tunnels to offer plenty cavity for molecules of drug. A light stimuli-responsive ligand, which is a derivative from light-responsive precursor 4,5-diazafluoren-9-one (indicated in the paper as DAFO), was further connected to the MCM-41 tunnels. The ligand can be excited by light and will flip over, making the tunnels of MCM-41 switch from close to open with light on and light off. The nanocomposite thus became capable of releasing drug molecules at certain wavelength of light. In the final, the nanoparticles were tested via SEM/TEM, XRD, FT-IR spectra, thermogravimetry and N2 adsorption/desorption to verify the structure. The MTT testing of our nanocomposite reveals no obvious cytotoxicity with non-morbid L929 murine fibroblast cells line, indicating that it could be used as a DDS candidate. The cargo releasing behaviors were studied on cytarabine loaded composite: DAFO@MS@Fe3O4 in simulated body fluids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  • Babu A, Templeton AK, Munshi A, Munshi A, Ramesh R (2013) Nanoparticle-based drug delivery for therapy of lung cancer: progress and challenges. J Nanomater 2013:14. doi:10.1155/2013/863951

    Article  Google Scholar 

  • Cai Y, Ling L, Li X (2015) Light-stimulated cargo release from a core–shell structured nanocomposite for site-specific delivery. J Solid State Chem 226:179–185. doi:10.1016/j.jssc.2015.02.019

    Article  CAS  Google Scholar 

  • Catharine JR, Scott CK, ChanMyra L, Samuels JR (1991) Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs. Cancer Chemother Pharmacol 29:13–18. doi:10.1007/BF00686329

    Article  Google Scholar 

  • Chen Y, Mu S (2014) Core–shell structured Fe3O4 nanoparticles functionalized with rhodamine derived probe for the detection, adsorption and removal of Hg(II): a sensing system with ‘warning’ signal. Sens Actuators B Chem 192:275–282. doi:10.1016/j.snb.2013.10.135

    Article  Google Scholar 

  • Chhikara BS, Parang K (2010) Development of cytarabine prodrugs and delivery systems for leukemia treatment. Expert Opinion Drug Deliv 7:1399–1414. doi:10.1517/17425247.2010.527330

    Article  CAS  Google Scholar 

  • Delle PM, Corno M, Pedone A, Dovesi R, Ugliengo P (2014) Large-scale B3LYP simulations of ibuprofen adsorbed in MCM-41 mesoporous silica as drug delivery system. J Phys Chem C 118:26737–26749. doi:10.1021/jp507364h

    Article  Google Scholar 

  • DuBois SG, Krailo MD, Lessnick SL, Smith R, Chen Z, Marina N, Stegmaier K, Steven G (2009) Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer 52:324–327. doi:10.1002/pbc.21822

    Article  Google Scholar 

  • Farzaneh F, Leila T, Mehdi G (2007) Oxidation of alkenes with molecular oxygen and isobutyraldehyde catalyzed by immobilized vitamin B12 within Al-MCM-41.”. React Kinet Catal Lett 91:333–340. doi:10.1007/s11144-007-5101-9

    Article  CAS  Google Scholar 

  • Gao Q, Xu Y, Wu D, Sun Y, Li X (2009) pH-responsive drug release from polymer-coated mesoporous silica spheres. J Phys Chem C 113:12753–12758. doi:10.1021/jp9043978

    Article  CAS  Google Scholar 

  • Gao J, Ran X, Shi C, Cheng H, Cheng T, Su Y (2013) One-step solvothermal synthesis of highly water-soluble, negatively charged superparamagnetic Fe3O4 colloidal nanocrystal clusters. Nanoscale 15:7026–7033. doi:10.1039/C3NR00931A

    Article  Google Scholar 

  • He QJ, Shi JL (2011) Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem 21:5845–5855. doi:10.1039/C0JM03851B

    Article  CAS  Google Scholar 

  • Hilhorst MJ, Hendriks G, van Hout MW, Sillén H, van de Merbel NC (2011) HPLC-MS/MS method for the determination of cytarabine in human plasma. Bioanalysis 3:1603–1611

    Article  CAS  Google Scholar 

  • Kapoor S, Rajesh H, Aninda JB (2009) Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release. J Control Release 140:34–39. doi:10.1016/j.jconrel.2009.07.015

    Article  CAS  Google Scholar 

  • Kruk M, Mietek J (2001) Gas adsorption characterization of ordered organic-inorganic nanocomposite materials. Chem Mater 13:3169–3183. doi:10.1021/cm0101069

    Article  CAS  Google Scholar 

  • Li L, Tang S, Ding D (2012) A core–shell structured nanocomposite material for detection, adsorption and removal of Hg(II) ions in water. J Nanosci Nanotechnol 12:8407–8414. doi:10.1166/jnn.2012.6668

    Article  CAS  Google Scholar 

  • Li WP, Liao PY, Su CH, Yeh CS (2014) Formation of oligonucleotide-gated silica shell-coated Fe3O4–Au core–shell nanotrisoctahedra for magnetically targeted and near-infrared light-responsive theranostic platform. J Am Chem Soc 28:10062–10075. doi:10.1021/ja504118q

    Article  Google Scholar 

  • Lin Q, Huang Q, Li C, Bao C, Liu Z, Li F, Zhu L (2010) Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one-or two-photon process. J Am Chem Soc 31:10645–10647. doi:10.1021/ja103415t

    Article  Google Scholar 

  • Liu J, Jiang Y, Cui Y, Xu C, Ji X, Luan Y (2014) Cytarabine-AOT catanionic vesicle-loaded biodegradable thermosensitive hydrogel as an efficient cytarabine delivery system. Int J Pharm 473:560–571. doi:10.1016/j.ijpharm.2014.07.032

    Article  CAS  Google Scholar 

  • Ma YC, Gao Y, Wang Y, Li Y, Yang X (2011) Synthesis and application of new ruthenium dye containing 9, 9-[di-(2-ethylhexane]-4,5-diazafluorene ligand. Modern Appl Sci 5:232. doi:10.5539/mas.v5n4p232

    CAS  Google Scholar 

  • Phuphanich S, Maria B, Braeckman R, Chamberlain MA (2007) Pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt®) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study. J Neurooncol 81:2201–2208. doi:10.1007/s11060-006-9218-x

    Google Scholar 

  • Popat A, Jambhrunkar S, Zhang J, Yang J, Zhang H, Meka A, Yu C (2014) Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery. Chem Commun 50:5547–5550. doi:10.1039/C4CC00620H

    Article  CAS  Google Scholar 

  • Silva EJ, Rosa TP, Herrera DR, Jacinto RC, Gomes BP, Zaia AA (2013) Evaluation of cytotoxicity and physicochemical properties of calcium silicate-based endodontic sealer MTA Fillapex. J Endod 39:274–277. doi:10.1016/j.joen.2012.06.030

    Article  Google Scholar 

  • Tang F, Li L, Chen D (2012) Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 24:1504–1534. doi:10.1002/adma.201104763

    Article  CAS  Google Scholar 

  • Wang Y, Zhao Q, Han N, Bai L, Li J, Liu J, Wang S (2015) Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomed Nanotechnol Biol Med 11:313–327. doi:10.1016/j.nano.2014.09.014

    Article  CAS  Google Scholar 

  • Zheng YD, Guan XC, Li D, Wang AQ, Ke CQ, Tang CP, Yao S (2016) Novel diterpenoids from the twigs of Podocarpus nagi. Molecules 21:1282. doi:10.3390/molecules21101282

    Article  Google Scholar 

Download references

Acknowledgement

The authors would like to state gratitude to our hospital and university for their financial as well as facilities support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tieyu Chen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, F., Qin, X., Xiao, D. et al. Towards site-specific nanoparticles for drug delivery application: preparation, characterization and release performance. Chem. Pap. 71, 2385–2394 (2017). https://doi.org/10.1007/s11696-017-0233-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11696-017-0233-5

Keywords

Navigation